review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1359-6101(97)00037-3 |
P698 | PubMed publication ID | 9720757 |
P50 | author | Barbara Ensoli | Q21255143 |
Michael Stürzl | Q41520499 | ||
P2093 | author name string | B Ensoli | |
P2860 | cites work | Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells | Q24305320 |
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence | Q24561727 | ||
A novel endothelial-specific membrane protein is a marker of cell-cell contacts | Q24642987 | ||
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies | Q24678972 | ||
The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein | Q24680024 | ||
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region | Q28252310 | ||
Expression of fibroblast growth factors and their receptors in acquired immunodeficiency syndrome-associated Kaposi sarcoma tissue and derived cells | Q28262598 | ||
Disseminated Kaposi's sarcoma syndrome in young homosexual men | Q28281021 | ||
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M | Q28284457 | ||
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells | Q32163310 | ||
Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient | Q33489423 | ||
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6 | Q33602539 | ||
Expression of int-2 oncogene in Kaposi's sarcoma lesions | Q33894163 | ||
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results | Q34055989 | ||
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. | Q34155667 | ||
Platelet-derived growth factor BB induces functional vascular anastomoses in vivo | Q34165679 | ||
Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. | Q34209585 | ||
Angiogenic properties of human immunodeficiency virus type 1 Tat protein | Q34267637 | ||
Treatment of HIV-associated Kaposi's sarcoma with paclitaxel | Q34299276 | ||
Inactivation of Bcl-2 by phosphorylation | Q34340301 | ||
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma | Q34383343 | ||
The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission | Q34388952 | ||
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome | Q34693731 | ||
Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies | Q34731756 | ||
Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma | Q34733565 | ||
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma | Q34735185 | ||
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen | Q34735858 | ||
Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins | Q43566357 | ||
Endemic African Kaposi's sarcoma is not associated with immunodeficiency | Q43597052 | ||
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients | Q43823829 | ||
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. | Q43932714 | ||
The appearance of Kaposi sarcoma during corticosteroid therapy | Q43988225 | ||
Infectious human herpesvirus 8 in a healthy North American blood donor | Q44132374 | ||
Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. | Q44213622 | ||
Microsatellite instability in primary neoplasms from HIV+ patients | Q44222153 | ||
Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. | Q44677526 | ||
Birthplace and classic Kaposi's sarcoma in Italy. Associazione Italiana Registri Tumori | Q44737224 | ||
The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth | Q45292376 | ||
Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein | Q45734648 | ||
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. | Q45878585 | ||
Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma | Q46482018 | ||
An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma. | Q52200372 | ||
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. | Q52833089 | ||
Immunological Studies in Kaposi's Sarcoma in Uganda | Q54060229 | ||
Interferon-gamma marks activated T lymphocytes in AIDS patients. | Q54320989 | ||
Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. | Q54332249 | ||
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. | Q54565305 | ||
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. | Q55242415 | ||
Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue | Q56999807 | ||
Kaposi's sarcoma and KSHV | Q58283364 | ||
Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. | Q35426283 | ||
Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo | Q35565392 | ||
Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma | Q35732449 | ||
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis | Q35752847 | ||
Human herpesvirus 8 encodes a homolog of interleukin-6. | Q35876140 | ||
Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma | Q35967211 | ||
Kaposi's sarcoma in mainland Tanzania: a report of 117 cases | Q36037978 | ||
Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution | Q36039507 | ||
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells | Q36366617 | ||
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. | Q36366989 | ||
Cytokines and endothelial cell biology | Q36565690 | ||
Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance | Q37133813 | ||
Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells | Q38359607 | ||
High incidence of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in Uganda | Q38887862 | ||
Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals | Q38888150 | ||
Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa | Q39122647 | ||
A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma | Q39435212 | ||
The human hematopoietic colony-stimulating factors | Q39656937 | ||
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis | Q40665903 | ||
Clinical aspects of AIDS-related Kaposi's sarcoma | Q40770536 | ||
Scatter factor and angiogenesis | Q40951683 | ||
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma | Q40972068 | ||
Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma | Q41100256 | ||
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. | Q41247263 | ||
Isolation and Characterization of an Immortal Neoplastic Cell Line (KS Y-1) From AIDS-Associated Kaposi's Sarcoma | Q41327013 | ||
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. | Q41335848 | ||
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma | Q41435232 | ||
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals | Q41472104 | ||
Cytokine regulation of endothelial cell function: from molecular level to the bedside | Q41472342 | ||
Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation | Q41534380 | ||
Kaposi's sarcoma in organ transplant recipients: report of 20 cases | Q41593468 | ||
AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor | Q41633966 | ||
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis | Q41671465 | ||
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients | Q41734588 | ||
Cytochemical and molecular properties of simian virus 40 transformed Kaposi's sarcoma-derived cells: evidence for the secretion of a member of the fibroblast growth factor family | Q41760163 | ||
Inhibition of endothelial cell growth by macrophage-like U-937 cell-derived oncostatin M, leukemia inhibitory factor, and transforming growth factor beta1. | Q42522979 | ||
Cyclin encoded by KS herpesvirus | Q42633290 | ||
Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions | Q58366797 | ||
Over-expression of hepatocyte growth factor in human Kaposi's sarcoma | Q58907097 | ||
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice | Q59060595 | ||
Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate | Q59071792 | ||
Kaposi's Sarcoma–Associated Herpesvirus DNA Sequences in Prostate Tissue and Human Semen | Q59647839 | ||
Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma | Q61641145 | ||
Immune response of elderly individuals to a live attenuated varicella vaccine | Q67492597 | ||
Cellular and molecular features of HIV-associated Kaposi's sarcoma | Q67548418 | ||
Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals | Q67986148 | ||
Kaposi's sarcoma: further immunohistologic evidence of a vascular endothelial origin | Q68060823 | ||
Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors | Q68447546 | ||
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome | Q68498654 | ||
Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon | Q68931996 | ||
Endothelial cell markers in vascular neoplasms: an immunohistochemical study comparing factor VIII-related antigen, blood group specific antigens, 6-keto-PGF1 alpha, and Ulex europaeus 1 lectin | Q68969090 | ||
Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas | Q69368465 | ||
Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma | Q69468698 | ||
Possible role of natural cytotoxic activity in the pathogenesis of AIDS | Q69735075 | ||
Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. An immunohistological study | Q69740016 | ||
Myopathy in McArdle's syndrome | Q69836175 | ||
Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins | Q69864531 | ||
Kaposi's sarcoma: a reversible hyperplasia | Q69890531 | ||
Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes | Q70474464 | ||
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells | Q71651411 | ||
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients | Q71735402 | ||
Herpesvirus-like DNA Sequences in Non-AIDS Kaposi's Sarcoma | Q71829854 | ||
Herpes-Like DNA Sequences, AIDS-Related Tumors, and Castleman's Disease | Q71980431 | ||
Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma | Q72058383 | ||
TGFβ and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcoma | Q72072566 | ||
Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1 | Q72100625 | ||
Kaposi's sarcoma and new herpesvirus | Q72172762 | ||
Immunohistochemical localization of transforming growth factor-beta 1 in Kaposi's sarcoma | Q72238371 | ||
Kaposi's sarcoma with benign course in a homosexual | Q72520368 | ||
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma | Q72633360 | ||
Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS) | Q72666198 | ||
A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals | Q72712217 | ||
Increased cytokine production in mononuclear cells of healthy elderly people | Q72921117 | ||
Activation of HHV-8 by HIV-1 tat | Q73164633 | ||
Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy | Q73236623 | ||
Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily | Q73236637 | ||
Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients | Q73427581 | ||
Clonality in Kaposi's sarcoma | Q73609603 | ||
Cell adhesion and angiogenesis | Q80120180 | ||
Spontaneous regression of Kaposi's sarcoma in patients with AIDS | Q93650974 | ||
P433 | issue | 1 | |
P921 | main subject | Kaposi's sarcoma | Q725345 |
P304 | page(s) | 63-83 | |
P577 | publication date | 1998-03-01 | |
P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
P1476 | title | Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents | |
P478 | volume | 9 |
Q38884285 | A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. |
Q59621919 | AIDS-associated malignancies |
Q41494543 | Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype |
Q33948194 | Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor |
Q30441657 | Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication |
Q34992555 | Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses |
Q33647345 | Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells |
Q36336086 | An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes |
Q64102452 | Arachidonic Acid Derived Lipid Mediators Influence Kaposi's Sarcoma-Associated Herpesvirus Infection and Pathogenesis |
Q36782271 | CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells. |
Q90266553 | Cancer prevention and control: Kaposi's sarcoma |
Q64263465 | Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication |
Q39597623 | Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains |
Q33984196 | Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome |
Q59353572 | Chemokine Subversion by Human Herpesviruses |
Q40067378 | Chemokines encoded by herpesviruses |
Q39748116 | De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells |
Q28359690 | Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells |
Q45723844 | Epstein‐Barr Virus and Human Herpesvirus 8 Coinfection and Concomitant Extranodal Nasal‐Type NK/T Cell Lymphoma and Castleman Disease: Case Report |
Q33824614 | Evasion and exploitation of chemokines by viruses |
Q47601651 | Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition |
Q40871620 | Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells |
Q35315503 | Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation |
Q61641137 | HHV-8 and multistep tumorigenesis |
Q40747284 | HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma |
Q47217828 | HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy |
Q34963626 | Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia |
Q26767036 | Historical review of the causes of cancer |
Q40860049 | Human endothelial cells expressing polyoma middle T induce tumors |
Q39733480 | Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence |
Q42202708 | Human herpesvirus 8 viral interleukin-6 signaling through gp130 promotes virus replication in primary effusion lymphoma and endothelial cells |
Q34295801 | Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. |
Q36238078 | Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma |
Q47367466 | Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. |
Q37209090 | Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation |
Q40364647 | Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. |
Q42710003 | Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells |
Q35752316 | Inhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells |
Q40438343 | Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival. |
Q33491306 | Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells |
Q34615002 | Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system |
Q37033410 | Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6 |
Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
Q98299755 | KSHV enhances mesenchymal stem cell homing and promotes KS-like pathogenesis |
Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
Q94012444 | Kaposi sarcoma |
Q41919772 | Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes |
Q37632632 | Kaposi's Sarcoma-Associated Herpesvirus Subversion of the Anti-Inflammatory Response in Human Skin Cells Reveals Correlates of Latency and Disease Pathogenesis |
Q44277985 | Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. |
Q39683376 | Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production |
Q33960391 | Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma. |
Q28388436 | Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1 |
Q24629364 | Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells |
Q40105629 | Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages |
Q39792755 | Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes. |
Q35641026 | Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis |
Q36363240 | Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression |
Q35785255 | Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1 |
Q36506932 | Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. |
Q39305101 | Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1. |
Q37478443 | Lung Malignancies in HIV Infection |
Q40218296 | Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus |
Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
Q34013830 | Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication |
Q40031635 | Opposing roles of RNA receptors TLR3 and RIG-I in the inflammatory response to double-stranded RNA in a Kaposi's sarcoma cell line |
Q92278120 | PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment |
Q35174136 | Pathogenesis of Kaposi's sarcoma |
Q36546999 | Professional antigen presenting cells in human herpesvirus 8 infection |
Q52561164 | RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses by N6 -methyladenosine (m6 A). |
Q34295807 | Reactivation and role of HHV-8 in Kaposi's sarcoma initiation |
Q34291063 | Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression |
Q55338587 | Role of Pattern Recognition Receptors in KSHV Infection. |
Q28829309 | Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus |
Q39776585 | Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein |
Q47606690 | TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway |
Q35066362 | The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis |
Q57160789 | The RNA epitranscriptome of DNA viruses |
Q37288834 | The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells |
Q39860135 | The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. |
Q35590378 | Treatment of Disseminated Classic Type of Kaposi's Sarcoma with Paclitaxel |
Search more.